First Report in a Human of Successful Treatment of Asthma with MesenchymalStem Cells: A Case Report with Review of Literature

间充质干细胞 医学 哮喘 脐带 干细胞 不利影响 干细胞疗法 免疫学 内科学 病理 生物 遗传学
作者
Joshua Sharan,Amir Barmada,Nicolas Band,Eliana Liebman,Chadwick C. Prodromos
出处
期刊:Current stem cell research & therapy [Bentham Science Publishers]
卷期号:18 (7): 1026-1029 被引量:13
标识
DOI:10.2174/1574888x18666221115141022
摘要

INTRODUCTION: Asthma is a heterogeneous disorder characterized by chronic airway inflammation resulting in obstructive pulmonary symptoms. In preclinical studies, mesenchymal stem cells (MSCs) have demonstrated the ability to ameliorate the symptoms and immunologic pathways seen in asthma. Due to the known relationship between asthma and the hyper-responsive immune cascade, we hypothesized that MSCs could be an effective treatment option for patients with asthma due to their significant immunomodulatory properties. OBJECTIVE: We present the initial results for the first patient enrolled in a phase 1 clinical trial (Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Pulmonary Diseases). CASE REPORT: A 68-year-old male with a longstanding history of asthma requested mesenchymal stem cell treatment for his persistent asthma symptoms. Cultured umbilical cord-derived mesenchymal stem cells were infused intravenously at a dose of 100 million cells over a period of 40 minutes. Post-treatment follow- up was performed after two and six months. RESULTS: The patient had no adverse events or complications related to treatment. In the two months posttreatment, his usage of a rescue inhaler decreased to 1 time per month, over 90% reduction. In addition, he had a 70% reduction in nebulizer usage. Improvement was sustained in the 6 months follow-up. CONCLUSION: We report the first case of mesenchymal stem cell treatment significantly and safely improving asthma clinical symptoms in a human. Additionally, an extensive literature review provided several plausible mechanisms by which stem cells can ameliorate immune hyper-stimulation associated with asthma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
wangweisky发布了新的文献求助10
1秒前
潇洒小松鼠完成签到,获得积分20
1秒前
potatoes完成签到,获得积分10
1秒前
beichen完成签到,获得积分10
2秒前
charint完成签到,获得积分10
2秒前
gonna完成签到,获得积分10
3秒前
成就半梦完成签到,获得积分10
3秒前
回忆里才完整完成签到,获得积分10
3秒前
连夏之发布了新的文献求助10
4秒前
嘻嘻滑呀完成签到,获得积分10
4秒前
星许完成签到 ,获得积分10
5秒前
5秒前
XMUyxy完成签到,获得积分10
5秒前
山复尔尔发布了新的文献求助10
5秒前
spell完成签到,获得积分20
5秒前
6秒前
英姑的应助被blink_gmx采纳,获得10
6秒前
8秒前
JIn完成签到,获得积分10
9秒前
慕青的应助被星空采纳,获得10
10秒前
10秒前
朴艺晨完成签到 ,获得积分10
11秒前
Full完成签到,获得积分10
11秒前
天天快乐的应助被峰峰采纳,获得10
11秒前
11秒前
洛玥完成签到 ,获得积分10
12秒前
鄂老三完成签到,获得积分10
12秒前
山复尔尔完成签到,获得积分10
12秒前
13秒前
做文章要专心完成签到 ,获得积分10
13秒前
理想红猪发布了新的文献求助10
14秒前
zzi发布了新的文献求助10
14秒前
厉奕欣完成签到 ,获得积分10
15秒前
janeli完成签到 ,获得积分10
15秒前
wangweisky发布了新的文献求助10
15秒前
xh93完成签到,获得积分10
16秒前
Mia完成签到,获得积分10
16秒前
妍三微月完成签到 ,获得积分10
16秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186353
求助须知:如何正确求助?哪些是违规求助? 9574789
关于积分的说明 21838002
捐赠科研通 7783987
什么是DOI,文献DOI怎么找? 3434752
关于科研通互助平台的介绍 2559147
邀请新用户注册赠送积分活动 2481535